These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 779574)
1. The management of hyperlipidemia: whether, rather than how. Ahrens EH Ann Intern Med; 1976 Jul; 85(1):87-93. PubMed ID: 779574 [TBL] [Abstract][Full Text] [Related]
3. Dietary and drug treatment of hyperlipidaemia. A feasibility study in asymptomatic middle-aged men. Hedstrand H Ups J Med Sci; 1976; 81(2):85-92. PubMed ID: 183322 [TBL] [Abstract][Full Text] [Related]
4. Hypolipaemic drugs and coronary heart disease. Howard AN J Clin Pathol Suppl (R Coll Pathol); 1975; 9():106-14. PubMed ID: 783209 [No Abstract] [Full Text] [Related]
5. [Hyperlipidemia and coronary disease]. Krikler DM Coeur Med Interne; 1976; 15(1):3-10. PubMed ID: 793762 [No Abstract] [Full Text] [Related]
6. Control of coronary heart disease--treatment of hyperlipidemia. Margolis S; Baker BM Johns Hopkins Med J; 1969 Apr; 124(4):224-30. PubMed ID: 5774147 [No Abstract] [Full Text] [Related]
8. Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis. Circulation; 1984 May; 69(5):1067A-1090A. PubMed ID: 6368042 [No Abstract] [Full Text] [Related]
9. [The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis]. Bavina MV; Perova NV; Lobova NM; Koropova GI Kardiologiia; 1973 Mar; 13(3):27-33. PubMed ID: 4717180 [No Abstract] [Full Text] [Related]
11. Treatment of hypercholesterolemia. Grundy SM Am J Clin Nutr; 1977 Jun; 30(6):985-92. PubMed ID: 326023 [No Abstract] [Full Text] [Related]
12. Treatment of type II and type IV Fredrickson's hyperlipoproteinemia. Crepaldi G; Fellin R; Briani G Adv Exp Med Biol; 1973; 38():199-217. PubMed ID: 4766527 [No Abstract] [Full Text] [Related]
13. Treatment of hyperlipidemic states. Strisower EH; Adamson G; Strisower B Med Clin North Am; 1970 Nov; 54(6):1599-613. PubMed ID: 5487683 [No Abstract] [Full Text] [Related]
14. Treatment of the hyperlipidemic states with special emphasis on the place of cholestyramine in therapy. Casdorph HR Angiology; 1970 Nov; 21(10):654-60. PubMed ID: 5480092 [No Abstract] [Full Text] [Related]
15. [Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)]. Kaffarnik H; Schneider J; Haase W Dtsch Med Wochenschr; 1975 Nov; 100(48):2486-8. PubMed ID: 1104303 [TBL] [Abstract][Full Text] [Related]
16. Clofibrate and niacin in coronary heart disease. JAMA; 1975 Jan; 231(4):360-81. PubMed ID: 1088963 [No Abstract] [Full Text] [Related]
17. Control of biochemical precursors of coronary heart disease. Ostrander LD Geriatrics; 1969 Dec; 24(12):61-6. PubMed ID: 5353631 [No Abstract] [Full Text] [Related]
18. The treatment of hyperlipidemia. Lees RS; Wilson DE N Engl J Med; 1971 Jan; 284(4):186-95. PubMed ID: 4923684 [No Abstract] [Full Text] [Related]
19. Dietary and pharmacologic therapy for the lipid risk factors. JAMA; 1983 Oct; 250(14):1873-9. PubMed ID: 6620484 [No Abstract] [Full Text] [Related]
20. Management of blood lipid abnormalities in coronary heart disease patients. Kuo PT Clin Cardiol; 1989 Oct; 12(10):553-60. PubMed ID: 2680196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]